Easily missed? Acromegaly

BMJ (Online)

Volumn 341, Issue 7769, 2010, Pages 400-401

  Reddy, Raghava ^a   Hope, Sally ^a   Wass, John ^a  

^a Department of Endocrinology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; OCTREOTIDE; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; ANAMNESIS; ARTICLE; BACKACHE; CASE REPORT; FEMALE; HUMAN; HYPOPHYSECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYMPTOM; DIAGNOSTIC ERROR; MALE; MIDDLE AGED; REVIEW;

ACROMEGALY; ADULT; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 77956131804     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wass JAH, ed. Handbook of acromegaly. 2nd ed. Bioscientifica, 2009.
2. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999;2:29-41.
3. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006;91:4769-75. [Abstract/FREE Full text]
4. Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol 2010;72:377-82. [CrossRef] [Medline]
5. Melmed S. Medical progress: acromegaly. N Engl J Med 2006;355:2558-73. [FREE Full text]
6. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25:102-52. [Abstract/FREE Full text] (Pubitemid 38269977)
7. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 1994;41:95-102. [Medline] (Pubitemid 24232533)
8. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000;85:526-9. [Abstract/FREE Full text]
9. Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 2004;89:667-74. [Abstract/FREE Full text]
10. nd ed. Oxford: Oxford University Press, 2009, pp 124-34.
11. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JAH. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 1999;50:561-7. [CrossRef] [Medline]
12. Murray RD, Melmed S. A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. J Clin Endocrinol Metab 2008;93:2957-68. [Abstract/FREE Full text]
13. Freda PU, Wardlaw SL, Post KD. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 1998;89:353-8. [CrossRef] [Medline] [Web of Science]